We are delighted to add our latest Educational Series titled: Malignant pleural mesothelioma; recent developments in its treatment landscape. This review summarises developments in the treatment landscape in Australia, highlighting outcomes from a study of nivolumab and ipilimumab compared with chemotherapy in patients with unresectable disease.
The review includes guiding commentary from Dr Anthony Linton, a medical oncologist at the Concord Cancer Centre in Concord Repatriation General Hospital.
Please login below to download this issue (PDF)